H.R. 586 House Armed Forces and National Security
Vietnam Veterans Liver Fluke Cancer Study Act
STAGE 4 OF 8 — HOUSE FLOOR
Currently in the House. Last action: received in the senate and read twice and referred to the committee on veterans' affairs on Apr 8, 2025.
- House Introduced in House Jan 21, 2025
- House Referred to the House Committee on Veterans' Affairs. Jan 21, 2025
- House Referred to the Subcommittee on Health. Feb 25, 2025
- House Mr. Bost moved to suspend the rules and pass the bill, as amended. Apr 7, 2025
- House Considered under suspension of the rules. (consideration: CR H1435-1437) Apr 7, 2025
- House DEBATE - The House proceeded with forty minutes of debate on H.R. 586. Apr 7, 2025
- House At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed. Apr 7, 2025
- House Considered as unfinished business. (consideration: CR H1441-1442) Apr 7, 2025
- House Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 411 - 0 (Roll no. 89). (text: CR H1435-1436: 1) Apr 7, 2025
- House On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 411 - 0 (Roll no. 89). (text: CR H1435-1436) Apr 7, 2025
- House Motion to reconsider laid on the table Agreed to without objection. Apr 7, 2025
- HouseOn Motion to Suspend the Rules and Pass, as Amended Apr 7, 2025
- Senate Received in the Senate and Read twice and referred to the Committee on Veterans' Affairs. Apr 8, 2025
Cosponsors
8
Subjects
AsiaCancerConflicts and warsCongressional oversightGovernment studies and investigationsHealth information and medical recordsMedical researchVeterans' medical careVietnam
Committees
- Veterans' Affairs Committee
- [Referred To, Apr 8, 2025]
- Veterans' Affairs Committee
- [Referred To, Jan 21, 2025]
Summary
Vietnam Veterans Liver Fluke Cancer Study ActThis bill requires the Department of Veterans Affairs (VA) to conduct an epidemiological study and report on the prevalence of cholangiocarcinoma (bile duct cancer) in veterans who served in the Vietnam theater of operations during the Vietnam era. The study must identify the rate of incidence of cholangiocarcinoma in such veterans and in U.S. residents.The bill also requires the VA to track and report on the prevalence of cholangiocarcinoma using the Veterans Affairs Central Cancer Registry. Additionally, the VA must periodically submit follow-up reports to Congress regarding the epidemiological study and information collected from the cancer registry regarding the prevalence of bile duct cancer.
[Summary as of: Introduced in House]
Comments · 0
Please log in to post a comment.
Loading comments...